Standard PK/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf.
about
Pharmacokinetic/Pharmacodynamic Modeling of Tulathromycin against Pasteurella multocida in a Porcine Tissue Cage Model.Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens.Addressing Antimicrobial Resistance: An Overview of Priority Actions to Prevent Suboptimal Antimicrobial Use in Food-Animal ProductionComparison of veterinary drugs and veterinary homeopathy: part 2.Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.A large potentiation effect of serum on the in vitro potency of tulathromycin against Mannheimia haemolytica and Pasteurella multocida.What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida?Pharmacodynamic Evaluation and PK/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for Streptococcus suis Infection.PK-PD Analysis of Marbofloxacin against Streptococcus suis in Pigs.PK-PD Integration Modeling and Cutoff Value of Florfenicol against Streptococcus suis in Pigs.The pharmacokinetic-pharmacodynamic modeling and cut-off values of tildipirosin against Haemophilus parasuis.En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach.Pneumatic dart delivery of tulathromycin in calves results in lower antimicrobial concentrations and increased biomarkers of stress and injection site inflammation compared to subcutaneous injection.Pharmacokinetics and Pharmacodynamics of Tildipirosin Against Pasteurella multocida in a Murine Lung Infection Model.
P2860
Q33843052-1550B17F-B98C-4F90-A3CE-205124AD4214Q36383878-6737B32D-AEBB-457A-999C-1D60FCB2E7E1Q36413575-67BCE654-293A-4B5C-B749-F1A710AD0306Q37562401-ED42BAD3-CCA5-4AD7-A86F-815E08F6F046Q38617982-256B19D6-F0D0-411B-9AA6-C488019DB3D5Q38699731-199D9940-9665-4BC8-9529-BAE040B014E9Q39019096-7762EA7E-A2AB-497D-8B98-DD829005455EQ39149738-8DCF6C80-9D8B-4E4D-97AB-9434A4D6715FQ42359420-CDE1348C-B3AE-4D3A-83B0-4F4A9A661953Q42369923-403C2785-E327-49A0-93AA-979B702FE9EAQ47362352-9D4ED8CE-D6EB-4153-A34A-302752FDA37EQ47701094-D2036A55-9FDA-4306-9265-8C91A9634707Q49210057-BA578B97-9835-4B1F-82ED-0EFDC5F56F5FQ49429759-8C7A4E6B-EF61-4FA8-847D-F16B802D71A3Q54976892-C29E1F37-8C22-4897-9AE2-83019054B7ECQ55364168-AB8F2204-679F-4538-850C-CA327E65FA3F
P2860
Standard PK/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Standard PK/PD concepts can be ...... of tulathromycin in the calf.
@en
type
label
Standard PK/PD concepts can be ...... of tulathromycin in the calf.
@en
prefLabel
Standard PK/PD concepts can be ...... of tulathromycin in the calf.
@en
P2093
P2860
P356
P1476
Standard PK/PD concepts can be ...... e of tulathromycin in the calf
@en
P2093
P2860
P356
10.1111/JVP.12333
P50
P577
2016-08-08T00:00:00Z